[Diagnostic value of 10 systematized and ultrasound-guided transrectal prostatic biopsies]

Prog Urol. 1998 Dec;8(6):1012-7.
[Article in French]

Abstract

Objective: To study the improvement of prostatic cancer detection provided by ten strictly systematized transrectal prostatic biopsies.

Material and methods: This prospective study was conducted in 162 patients submitted to a series of 10 ultrasound-guided transrectal prostatic biopsies due to the presence of elevated PSA and/or an abnormality on digital rectal examination. Five biopsies were taken from different sites in each lobe: 2 biopsies were inserted between the 3 biopsies usually performed in the standard protocol, while maintaining the angle of entry of the needle recommended in this protocol.

Results: The complication rate was 1.85% with the 10-biopsy technique. Prostatic cancer was detected in 40.1% of the 162 patients. The percentage diagnostic improvement provided by the 10-biopsy protocol in the overall patient population was +3.1% compared to the standard protocol. The highest percentage diagnostic improvement was observed in the group of patients with PSA < or = 10 ng/ml (+4.9%) and in the group of patients with an ultrasound prostatic volume < or = 40 cc (+4%).

Conclusion: The most marked diagnostic improvement appears to be related more to sampling of prostatic zones presenting a statistically increased risk of cancer (peripheral zone) than to the increased number of prostatic biopsies performed.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / pathology*
  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy / methods*
  • Diagnosis, Differential
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Prostate / pathology*
  • Prostate-Specific Antigen / blood
  • Prostatic Hyperplasia / diagnosis*
  • Prostatic Hyperplasia / pathology*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / pathology*
  • Ultrasonography

Substances

  • Prostate-Specific Antigen